[lbo-talk] Re: lbo-talk Digest, Vol 12, Issue 164

hari.kumar at sympatico.ca hari.kumar at sympatico.ca
Wed Dec 22 12:40:19 PST 2004


"Leigh Meyers" <leigh_m at sbcglobal.net> Subject: Re: [lbo-talk] GM something...

It is becoming increasingly clear that the side-effects in this set of drugs represent a true so-called "class effect"; & not one related to an individual drug. Recall that much drug company "research" is in essence molecular rouletting to get around patents, this makes perfect sense.

The real hero is a Dr David Grham - whistle blower at the FDA. See for eg: http://www.forbes.com/home/sciencesandmedicine/2004/12/13/cx_mh_1213faceoftheyear.html

Somewhere recently in the Lancet is an article totting up the attributable preventable deaths to the Merck brand. It was huge. These happened after the company was well aware of the side-effect. Hari



More information about the lbo-talk mailing list